Template:Factor Xa Inhibitor Reversal

Revisión del 13:13 28 abr 2016 de Rossdonaldson1 (discusión | contribs.) (Created page with "===Factor Xa Inhibitor Reversal=== {| {{table}} | align="center" style="background:#f0f0f0;"|'''Anticoagulant''' | align="center" style="background:#f0f0f0;"|'''Half-life''' |...")
(difs.) ← Revisión anterior | Revisión actual (difs.) | Revisión siguiente → (difs.)

Factor Xa Inhibitor Reversal

Anticoagulant Half-life Removed by HD Strategies to reverse or minimize anticoagulant effects
Apixaban (Eliquis®) 8-15 hrs (longer in renal impairment) No
  • If ingested within 2 hours, administer activated charcoal
  • 4-factor PCC (Kcentra™)^
    • 25units/kg—max 2500 units for treatment of documented intracranial hemorrhage
    • 50 units/kg—max 5000 units for all other life-threatening bleeds
Edoxaban (Savaysa®) 10-14 hrs (longer in renal impairment) ~ 25% As above
Rivaroxaban (Xarelto®) 9-13 hrs (longer in renal impairment) No As above
Fondaparinux (Arixtra®) 17-21 hrs (significantly longer in renal impairment) No 4-factor PCC (Kcentra™)^ 50 units/kg—max 5000 units

^Off-label

Obtenido de «https://www.wikem.org/w/index.php?title=Template:Factor_Xa_Inhibitor_Reversal&oldid=66850»